7 Best Non-REIT Dividend Stocks to Invest in

5. Kimberly-Clark Corporation (NASDAQ:KMB)

Number of Hedge Fund Holders: 42

Dividend Yield as of January 31: 5.12%

Kimberly-Clark Corporation (NASDAQ:KMB) operates globally in personal care, with its business split between North America and international personal care markets.

On January 28, UBS analyst Peter Grom raised his price target on Kimberly-Clark Corporation (NASDAQ:KMB) to $110 from $107 and kept a Neutral rating. He said the core business remains steady, though the overhang tied to Kenvue is likely to linger, according to his research note.

A day earlier, on January 27, Kimberly-Clark Corporation posted quarterly profit that topped expectations. The results reflected tighter cost controls and consistent demand for everyday products like Huggies diapers and Kleenex tissues across North America, China, and other key markets.

In recent years, the Dallas-based company has made some tough choices. It reduced headcount and exited lower-margin businesses, including private-label diapers and personal protective equipment. Those steps helped defend margins. At the same time, management expanded its value-focused product lines, offering lower-priced options that still carry features shoppers associate with premium brands. The goal is straightforward: stay relevant for budget-conscious consumers without losing ground to competitors.

Kimberly-Clark is also in the middle of a larger shift. The company is repositioning itself as a global consumer health business following its $40 billion acquisition of Kenvue, the maker of Tylenol. The transaction is expected to close by year-end and represents a key piece of the company’s long-term strategy.